Science method
Biotransformation - Science method
Biotransformation is the chemical alteration of an exogenous substance by or in a biological system. The alteration may inactivate the compound or it may result in the production of an active metabolite of an inactive parent compound. The alterations may be divided into METABOLIC DETOXICATION, PHASE I and METABOLIC DETOXICATION, PHASE II.
Questions related to Biotransformation
Hello! I am currently working on my thesis on mercury bioremediation using bacteria. To assess whether biotransformation has occurred, I would like to seek your recommendations for simple analytical methods to determine if the transformation of mercury has taken place by the bacteria. I am looking for a straightforward and commonly available method, as more sophisticated analytical techniques may not be available in my location. Thank you in advance for your response!
Hello! I am currently doing my thesis on mercury bioremediation using bacteria. To understand the underlying mechanisms, I'm seeking your recommendations for suitable analytical techniques. I'm particularly interested in investigating processes like biodegradation, biotransformation, absorption, and adsorption. My current proposals include Scanning Electron Microscopy - Energy Dispersive X-Ray Spectroscopy (SEM-EDS) to examine bacterial-mercury interactions, Atomic Absorption Spectroscopy (AAS) to assess mercury transformation, and UV-Vis Spectrophotometry to quantify mercury removal.
Hi everyone,
I'd like to better separate two close peaks coming from a bioconversion sample, I'm currently using a C18 KromaPhase 4,6mm Ø.I. SCHARLAU, particle size (µm): 10, pore size (Å): 100, length (mm): 250, internal Ø (mm): 4,6, with 10/90% acetonitrile/water (0.1% formic acid) as mobile phase at the temperature of 20 °C. I've also tried with 5/95% ACN/water as mobile phase obaiting a better separation, but I've read that is not very good to work with a organic percentage lower than a 10%. I'm open to any suggestion to improve my hplc method. Thank you
- I work on producing organic fertilizer from rice husk. how can I reduce the bio-conversion time ?less than two months
Hello,
I am in search for papers that:
1) explain with graphs the biotransformation of diosgenin to cortisone.
2) explain with graphs the biotransformation of soybean oil to progesterone.
If there are DOIs or any the likes than please send it over.
Thank you for your assist
I am trying to investigate the process of biotransformation of plant materials using insect larvae. Is it necessary for delignification process be first carried out?
My compounds is choloro benzaldehyde and it is insoluble in water , i am willing to do biotransformation in LB (Lysogeny Broth )media , what should i do?
My compounds is choloro benzaldehyde and it is insoluble in water , i am willing to do biotransformation in LB (Lysogeny Broth )media , what technique might be useful which doesn't affect yeast cells also?
For a drug that is practically insoluble in water and sparingly soluble in ethanol and DMSO, how may each of the following factors be manipulated to maximize the drug exposure when applied into a sustained-release injection (parenteral or IV) formulation?
- particle size distribution
- API crystal form (anhydrous/monohydrate) -> any effect?
- suspension solution (aqueous/oil)
- route of administration (SC/IV/IM)
- metabolizing enzyme induction/inhibition (CYP/UGT)
I am working with some new drugs and looking for biotransformations. We have done the MS/MS of drug-treated bacterial lysates and found the presence of some signature masses matching the fragments of the mother drug, so we are assuming that it can be the biotransformation of the mother drug.
We have a list of m/z and need to deduce the structure from it.
I have used Agilent QTOF.
Can anyone suggest that how can we do that?
I have used SIRIUS but not helpful.
As we know numerous lignocellulosic biomass (such as forestry residue, crop residue, industrial products, food wastes, etc) have been used in bioconversion research studies but my question is how much type of lignocellulosic biomass we choose as raw material affect the efficiency of the process and should a particular type emphasized more?
Dear colleagues,
in your opinion, what is an appropriate tool to model biotransformation processes in silico. Optimally, the system should predict metabolites and define the involved phase I and II enzymes. Thereby, it would be handy if the tool is user friendly. Hence, it should not require absolute expertise in the involved biochemistry processes.
Any input is very welcomed.
Thanks and best regards
Sebastian
I obtained 2 compounds after a biotransformation reaction. I have isolated the compounds using column chromatography and have characterized them. I need to calculate the yield of the compounds.
We started a new Podcast focusing on Biocatalysis and Biotransformations. The idea is to interview all invited speakers and keynote speakers of the upcoming Biotrans 2021 in Graz.
We would be very interested in your critique, comments, questions, or suggestions.
Check it out here or at the Podcast platform of your choice: https://anchor.fm/in-the-active-site
I am studying arsenic biotransformation by bacteria and I need to check the morphological changes on the bacterial cells after exposure to arsenic. I also need to check if there's any arsenic accumulation or adsorption in the bacterial cell. How can I best prepare my sample for this purpose? We don't have critical point drying machine here so is there any other alternative to this? Thank you.
Hi, I've been looking for literature regarding the production of metabolites that are produced primarily by the host and then biotransformed by Lactobacillus to antifungal compounds. Does anyone has seen something like that? Thanks!
PD. An example would be this article:
In our country, a lot of water sources are found to be contaminated with arsenic (As). But, here, experts said that, using arsenic contaminated water is not harmful for us, we can use it in our daily needs except drinking.
My question is - using arsenic contaminated water for our daily needs, have any risk of bioaccumulation by surrounding biota? Does it have any associated human health risk?
Chromium is one of the main chemical ingredients of tannery industries. Those industries also produce a lot of chromium contaminated solid wastes. what are the biotransformation and bioaccumulation procedures it follows to expose in human body?
How I delignified of the cellulose? Which chemical are suitable to delignification?
In preeclamptic or eclamptic patients with significantly decreased liver and kidney functions, can we temporarily use a positive cardiac inotrope or a vasopressor to increase blood flow to these organs to help prevent decreased biotransformation and renal clearance? If so, how can left ventricular hypertrophy can be prevented? Can we use renin-angiotensin-aldosterone antagonists such as enalapril or a cardiac beta 1 selective blocker postpartum?
I ask because I am a grad student researching microbial plastic biotransformation and I would like to work on polyethylene due to its ubiquity, but recognize it may be more practical to address plastics for which the key enzymes are more established.
Hello all, I am working on one of the flavour molecule producing it through biotechnological route. I have two recombinant genes that are involved in the enzymatic reaction that are transformed in E.coli Bl21. While setting the biotransformation reaction with the substrate along with the whole E.coli cells and lysed cells, whole cells are giving me better conversions as compared to lysed cells. My question is when i am using the fresh whole cells its conversion is less as compared to the cells resuspended in phosphate buffer ph7 and then stored at 4C (refrigerator) for one two weeks. why?
please if you have any publication on this question you can add it to the answers. Thanks
I like to collaborate with your project group on Biocatalysis and biotransformation of vegetable oils to alkyl esters. Could you please assist this collaboration by sharing essential research materials to the scope.
Regards
Mustapha
I am working on my thesis work, hepatic biotransformation of some biactive compounds extracted from natural products in rat microsomal fraction (S9), for which I need to know the possible enzymatic reactions that will happen and the probable structures of the metabolites.
I want to interpolate the amount of product formed (as concentration or % of conversion) vs reaction time in a biocatalysis process. The fitting equation should have as (y) the amount of product and as (x) the reaction time. I thought to use as the fitting equation the integrated form of the M&M but I am not able to find the correct mathematical form. Or should I use another equation?
As an instruction based experiment for undergrad class, I am looking for simplest experiment design for above mentioned process
Hi all,
One widely accepted rule in biochemistry/pharmacology is that biotransformation is require for compounds with logD>=1 at pH = 7.4. Are there any known cut-offs that do not rely on the logD but other physico-chemical properties?
Thanks,
Yannick
I've found, through literature review, that the major product of CYP3A4 coumarin hydoxylation is 3-hydroxycoumarin rather than 7-hydroxycoumarin, the major product of human coumarin metabolism. I know that 7-hydroxycoumarin is glucoronidated and excreted in urine, but is 3-hydroxycoumarin also glucoronidated? I've found a source that says all hydroxylated coumarins are glucoronidated, but I've yet to see a paper that actually discusses glucoronidation of 3-hydroxycoumarin, nor have I found the compound through chemical suppliers like Sigma, which leads me to believe 3-glucoronidation might not typically occur.
I am working on the effect of lodging in rapeseed.Now I want to check enzymes in green pods
Any advice on Cytochromes P450 (CYP) panel on chemotherapy? What's your gene list? Clinically, Roche got an FDA-approved panel but is outdated and limited - do you have an updated list?
Cytochromes P450 (CYP) are a major source of variability in drug pharmacokinetics and response. Of 57 putatively functional human CYPs only about a dozen enzymes, belonging to the CYP1, 2, and 3 families, are responsible for the biotransformation of most foreign substances including 70–80% of all drugs in clinical use. The highest expressed forms in liver are CYPs 3A4, 2C9, 2C8, 2E1, and 1A2, while 2A6, 2D6, 2B6, 2C19 and 3A5 are less abundant and CYPs 2J2, 1A1, and 1B1 are mainly expressed extrahepatically.http://www.sciencedirect.com/science/article/pii/S0163725813000065
Actually I am working on the biotransformation of cyclopentanol to cyclopentanone by using an alcohol dehydrogenase and also I am working on the biotransformation of cyclopentanone to cyclopentanol as well .
I know that the best way to determine the product is GC-MS but as it costs a lot so before the GC-MS I want to get sure of the product formation by using TLC.
Can someone help or explain which may cause differences in processes of drug excretion from the organism of rats and mice (rat -fecal excretion of the drug predominated (70%), mice - excretion proceeded with equal efficiency in urine and feces). The drug is practically (80%) are not biotransformed, minor reactive metabolites are equally in rat and mice.
My previous attempt to raise this point was misdirected to the data on hydrophobic zone(s) in protein moiety of P-450 (CYP) influencing its active center’s substrate-binding and catalytic efficacy. In other words, membranous localization of monooxygenases is commonly ignored thus considering enzyme-kinetics of P450s as any other water-soluble enzymes. Inasmuch as the vast majority of modern medicines belonging to P45O substrates are relatively to highly lipophilic, and any pharnacy prescription drug information sheet contain data on drug-drug interactions, which occur at P450 active site, drugs' octanol-water partition coefficients (log P, by definition made by Hansch & Leo) values should be taken into calculations of Ks, Km, Vmax, Kcat, etc.
Nowadays, thirty years since we discussed the very point with Dr. Walter Pyerin of German Cancer Research Center, Heidelburg, his conclusions still sound very actual: “When the fluidity of the membrane was changed showing a well-defined gel to liquid crystalline phase transition, the activation energy of the monooxygenase reaction was changed at around the phase transition temperature, suggesting a conformational change of cytochrome P-450 caused by the fluidity change of the membrane. The incorporation of P-450 into liposomes was also found to affect the binding of substrates to cytochrome P-450. The decrease in the apparent dissociation constant of substrates upon incorporation into membranes suggests that the lipid membrane acts as a pool for hydrophobic substrates, which are concentrated in the lipid phase, and that cytochrome P-450 takes substrates directly from the membrane phase. Phospholipid membranes, therefore, play very important roles in various phases of the reaction of cytochrome P-450-dependent monooxygenase” (H. Taniguichi & W. Pyerin, Phospholipid bilayer membranes play decisive roles in the cytochrome P-450-dependent monooxygenase system. J Cancer Res Clin Oncol 114: 335-340, 1988).
I like to use e.coli cells (pellet) in buffer, which should convert a aromatic and low water soluble molecule. Could DMSO help to overcome the transport limitation ?
Or have someone expericence with digitonin e.g. ? http://en.wikipedia.org/wiki/Digitonin
When fungi is used to pretreat the lignocellulosic biomass, the mycelial mat is grown over it. It has to be separated from the mat so that the substrate can be used for further bioconversion steps. How is it done?
I am isolating bacteria degrading lignin on agar plate. I found one bacteria turn the lignin plate into dark quickly while the bacteria do not turn TSA or LB plate into dark. What is the mechanism for turning lignin into dark? That plate is made of lignin and some salts (Bushnell-Hass medium). What do you think is an indicator of good lignin-degrading bacteria?
Usually it is recommended to add glucose after sterilization of media.
Can anyone tell me, then how should we add glucose in the media?
We usually work on litres of media (4 to 8 L), for which we need 30 to 50 g glucose.
If we add solid glucose then there are chances of contamination.
Should we use microfilters?
Microfilters are very expensive.
Then what others?
In our experiments, we do not care how much glucose is oxidizing on heating in autoclave because our concern is to obtain enough growth of the culture for biotransformation.
I'm looking for any study that found fungal biotransformation of terpenes by the secretions of a fungi grown in agar petri dishes (or any solid substrate). That is, some fungus capable of biotranfsorming terpenes without "touching" them with the hyphae, but biotransform the terpene by secreting some substance (exoenzymes or similar). If you don't know about any study like this on terpenes, may you know about some with other substances? or with bacteria or any other organism?
I've been quite extensively searching about that and by now I have not been able to spot any article like this.
Thank you very much!
If a drug is biotransformed into a metabolite within 24 hours what will happen to that metabolite?
I used a fungal culture to biotransform a drug. After 24 hours I tested for metabolites using TLC, I got two spots below to the starting. But when I checked the same after 48 hours i didn't get the spots. What may be the reason?
I am working on polylactic acid production from lactose. After production of lactic acid, is there any biological (microbes/bioenzymes) which can convert it to polylactic acid? Direct conversion of lactose to polylactic acid by microbes is also desirable.
Biotransformation performed by microbes has advantage over chemical synthesis due to more "green" and higher chiral specificity. Rather than random screen, do you have any ideas to design a higher efficient way to screen bacteria that are potential useful? For example, to specifically convert C=O to C-OH, or vice verse. Another example, to add or remove some chemical groups through acting on glucosidic bonds in some carbohydrates.
Has anyone worked on nanoparticles using either X-ray absorption near edge structure (XANES) or Synchrotron radiation? I would appreciate an enlightenment on better techniques out of the two to examine biotransformation/speciation of nanoparticles in plant parts after uptake.
Plant secondary metabolites as thymol and carvacrol undergo glucuronidation and sulfation in liver, intestine and kidney. There are several isoforms of enzymes involved during this phase II of biotransformation.
Bio-transformations of natural and synthetic compounds are performed by using a large range of bacteria and fungi.
Can I use a magnetic stirrer for water insoluble compounds; or should I use emulsifying agents for this purpose?
I want to design an artificial metabolic pathway in bacteria or just using responsible enzymes to produce certain products such as H2 or other biofuels. Where can I start with? Do you have some thoughts about this?
Plant secondary metabolite as thymol undergo sulfation in the liver and other organ tissues. There are several isoforms of enzymes involved during this phase II of biotransformation. Result of this reaction is metabolite - thymol sulfate.
I am using arsenic transformng bacteria for reducing arsenate (V) to arsenite (III) in a soil sample. The soil sample is treated with water for one month. After one month I am analyzing the pH, electrical conductivity and oxidation reduction potential of the soil sample. I would like to know whether these three properties will increase or decrease after reduction of arsenate to arsenite after one month.
As a person working with biocatalysis in non-standard media I am also interested in solvent/enzyme relationships. It was found that there is a dependance of behaviour of enzymatic preparations in non-aqueous media from the logP (partition coefficient) value. Therefore, I need to find the value for the solvent mixtures I used - namely hexane:THF 7:3 and 1:1. I heard that it is possible to calculate these values - but never found how it is done. Can anyone be of some assistance?
I am working on the microbial transformation of triterpenes using A. niger
the microbe was incubated for 24 hrs in 30 c , then 10 mg of the substrate have fed to the microbe.
As a screening experiment I incubated the fungi with the substrate for 2, 4 and 6 days in 3 different conical flasks.
I harvest the and check on TLC, noted that the substrate very slightly or has not consumed at all.
And there was no any marks for any metabolite or transformed product?
I'm interested in screening lipases for a lactonization reaction. The substrate contains a secondary alcohol and a a carboxylic ester, so effectively looking for a transesterifcation reaction. The desired lactone would form a nine-membered ring. I'm aware of a number of kits available for screening immobilized lipases, but wondering if there is an obvious 1st choice for this type of reaction in an organic solvent. I have only experience using PPL, but this was to make alpha-omega lactones from omega-OH fatty acids(eg. C15-C18), not for internal lactones with substiutuents "beyond" the two reacting groups. Any advice appreciated
We already have in place HPLC/UPLC based methods, but these are ' stopped time' based, so tedious for kinetic studies. Looking for a colorimetric assay (eg. enzyme coupled?) that would target the co-product, S-adenosylhomocysteine. Any thoughts appreciated.